MedPath

A study to compare the clinical features of drugs 0.75% ropivacaine and the combination of ropivacaine 0.75% with fentanyl 25 mcg for spinal anaesthesia in patients undergoing perianal surgeries

Phase 1
Conditions
Health Condition 1: 8- Other Procedures
Registration Number
CTRI/2024/02/063007
Lead Sponsor
Dr ARUNKUMAR A BARASAKALE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a) Patients aged between 18 to 60 years of age posted for elective perianal

surgeries.

b) ASA grade I and II patient

Exclusion Criteria

a)Patients who has H/o coagulation and bleeding disorders.

b) Local site infections.

c) H/o hypersensitivity to study drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Time taken for ambulation without assistance.Timepoint: 24 hours
Secondary Outcome Measures
NameTimeMethod
1.Time to achieve T10 sensory block <br/ ><br>2.Maximum height of sensory block <br/ ><br>3.Duration of sensory block <br/ ><br>4.Duration of motor blockTimepoint: 24 HOURS
Âİ Copyright 2025. All Rights Reserved by MedPath